Translational Development Acquisition Cash Flow Statement (2024-2026) | TDAC

Cash Flow Statement Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M
Cash from Operations (Quarter) -0.81M-0.23M-0.17M-0.09M-0.12M-0.31M
Change in Working Capital
Change in Accured Expenses (Quarter) -0.47M0.09M-0.06M0.01M-0.01M-0.01M
Financing Activities
Cash from Financing Activities (Quarter) 175.25M0.10M0.30M
Additional items
Change in Cash (Quarter) 0.21M-0.23M-0.17M0.01M-0.02M-0.01M
Free Cash Flow (Quarter) -0.81M-0.23M-0.17M-0.09M-0.12M-0.31M
Net Cash Flow (Quarter) 174.44M-0.23M-0.17M-0.09M-0.02M-0.01M